LIGAND PHARMACEUTICALS INCORPORATED Available-for-sale Securities, Gross Unrealized Loss
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Available-for-sale Securities, Gross Unrealized Loss of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2015-02-23
- LIGAND PHARMACEUTICALS INCORPORATED available-for-sale securities, gross unrealized loss for fiscal 2014 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED available-for-sale securities, gross unrealized loss for fiscal 2013 was $0.00.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 12 month |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-02-23 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-23 |